New

Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

›ETF Providers›Invesco›IBBQ
ETF screener
IBBQ
US46138G5999
Passive ETFEquity

IBBQ ETF · Invesco Nasdaq Biotechnology ETF

The IBBQ Exchange Traded Fund (ETF) is provided by Invesco. It is built to track an index: NASDAQ Biotechnology Index. The IBBQ ETF provides physical exposure, so by buying it you actually own parts of all the 256 underlying holdings. This share class generates a stream of income by distributing dividends.
Last update Yesterday at 1:30 PM UTC
LIVE
CLOSED
This fund is part ofUS Health Care1M perf.-0.31%
Last price
$28.84
1M perf.
-1.29%
1M flows
-€6.6M
AuM
€56M
E/R
0.19%
Rating
Not rated
ESG Consensus®
esg grade icon
IBBQ
$28.84

Performance & flows

Segment for quartile rank
February 2, 2026 → May 1, 2026
0-8-6-4-2024%MARAPRMAYMARAPRMAY
Create a free account to view the flows graph
IBBQ
$28.83
-1.87%
US Health Care
-5.08%

Historic performance and flows

1M3M1Y3Y5YMTDQTDYTD
Perf.
-1.29%
icon
-1.87%
icon
+38.66%
icon
+40.14%
icon
N/A
-1.09%
-0.70%
+1.73%
icon
Flows

Key fund info

Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) Â· 
Main characteristics
Issuer
CUSIP
46138G599
ISIN
US46138G5999
AuM
€56M
icon
E/R
0.19%
icon
Replication rating
Not rated
ESG Consensus®
esg grade icon
icon
More details
NAV
5/1/2026
$28.83
1D NAV change
-1.09%
Dividend policy
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
256
Inception date
6/9/2021
Jurisdiction
United States
Distribution
United States
Legal structure
Open-end Investment Company
Base currency
USD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Product type
Asset class
Factors
N/A
Investment strategy
The Invesco Nasdaq Biotechnology ETF (Fund) is based on the Nasdaq Biotechnology Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The Fund and the Index are reconstituted annually in December and rebalanced quarterly in March, June, September and December.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
half moonhalf moon double
New to Trackinsight?
For individual investors

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.
More fund data
Compare up to 3 funds
More screener filters
Choose your own screener columns from 100+ metrics
Lists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring
For professional investors

Trackinsight
Enterprise

Trackinsight Enterprise addresses the everyday operational, regulatory, and analytical pain points faced by professional and institutional ETF investors, from selection to execution.
Request a free trial
More professional services:ETF Data ServicesDue Diligence Services

Similar ETFs in your region

BTEC
1M perf.
-1.30%
E/R
0.35%
203780
1M perf.
+2.43%
E/R
0.3%
IBB
1M perf.
-1.66%
E/R
0.44%
00678
1M perf.
+0.96%
E/R
1.01%
HTEC
1M perf.
+1.67%
E/R
0.8%

Advertisement

Risk profile

Segment for quartile rank

Historical risk/return profile

3M1Y3Y5Y
Returns
-1.87%
icon
+38.66%
icon
+40.14%
icon
N/A
Volatility
Perf./Volatility
Max drawdown
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
More exposure metrics are available, exclusively in Trackinsight Enterprise

Exposure

Countries
USA
92.77%
United Kingdom
1.86%
Bermuda
1.61%
Ireland
1.48%
Other
2.29%
Sectors
Health Care
85.90%
Unavailable
14.09%
Diversification
Total weight of top 15 holdings out of 256
Top 15 holdings
Data as of March 31, 2026
GILEAD SCIENCES
AMGEN-T
VERTEX PHARMACEUTICALS
REGENERON PHARMACEUTICALS
ALNYLAM PHARMACEUTICALS
INSMED
BIOGEN INC
UTD THERAPEUT
Create a free account to view top holdings
ROYALTY PHARMA
US04016X1019
MODERNA INC
ROIVANT SCIENCES LTD
REVOLUTION MEDICINES INC
ILLUMINA
INCYTE
Create a free account to view top holdings
More risk metrics are available, exclusively in Trackinsight Enterprise

Sustainability

Integrates ESG criteria
No
SDG

ESG Consensus® by Conser

Data as of February 27, 2026
Methodology

Our partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about IBBQ ETF's sustainability, based on their methodology.

Learn more about Conser

ESG Consensus®
esg grade icon

ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.


IBBQ’s has a Final Sustainability Grade of either B+, B, or B-.

This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight Enterprise
Holdings review
88.40% of holdings have positive scoring
11.60% of holdings have negative scoring
5.33%
60.92%
22.15%
6.54%
Consensus levels
Strong
Medium
Weak
More sustainability metrics are available, exclusively in Trackinsight Enterprise

Replication

Trackinsight replication rating:
Not rated
1-year trailing difference
As of April 30, 2026
Create a free account to view the replication graph
IBBQ
N/A
Replication quality
Calculated over 12m, as of April 30, 2026
Tracking error
Tracking difference
1-year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Replication information
Index
Index ticker
Index dividend policy
Replication method
Replication model

Issuer

Invesco
Invesco ID Card
Number of funds
633
Total AuM
€920.87B
Expense ratio range
0.04% - 5.39%
Average expense ratio
0.3558%
Top 5 funds by Invesco
AuM
QQQ
Invesco QQQ ETF€375.65B
RSP
Invesco S&P 500® Equal Weight ETF€74.32B
QQQM
Invesco NASDAQ 100 ETF€71.66B
SPXS
Invesco S&P 500 UCITS ETF€32.32B
SGLD
Invesco Physical Gold USD ETC€25.26B

Frequently asked questions about IBBQ

What does Invesco Nasdaq Biotechnology ETF, IBBQ, invest in?

IBBQ is a Passive ETF. This ETF provides exposure to US Equities.

Which benchmark or index does IBBQ replicate?

IBBQ tracks the NASDAQ Biotechnology Index - USD, through a full replication replication method.

What is the Total Expense ratio (TER) of IBBQ?

IBBQ carries a total expense ratio (TER) of 0.19%, indicating the annual cost for holding the fund.

When was IBBQ launched?

IBBQ was introduced to the market on June 9, 2021. It trades on United States

Who is the ETF issuer of IBBQ?

Invesco Nasdaq Biotechnology ETF, IBBQ, is provided by Invesco. Learn more about Invesco here.

What is the current assets under management (AUM) of IBBQ?

IBBQ oversees €56M in assets as of May 1, 2026.

How has IBBQ performed lately?

Based on data from May 1, 2026, IBBQ returned -1.29% over the past month, -1.87% over the last three months and 1.73% year-to-date.

What are the latest inflows or outflows for IBBQ?

As of May 1, 2026, IBBQ recorded net flows of -€6.6M over the last month and +€192K year-to-date.

Does IBBQ distribute dividends?

IBBQ follows a distributing dividend policy, meaning it pays out income to investors. As of May 1, 2026, its 12-month trailing yield was 0.87%.

What are the main country or region exposures of IBBQ?

As of March 31, 2026, IBBQ has significant geographic allocations in USA, United Kingdom and Bermuda.

In which sector or theme does IBBQ invest in?

As of March 31, 2026, IBBQ focuses largely on Health Care.

How many securities does IBBQ hold and how diversified is it?

As of March 31, 2026, IBBQ holds 256 positions in its portfolio, with 51.37% of assets concentrated in its top 15 holdings.

What are the main positions in IBBQ?

As of March 31, 2026, IBBQ top three holdings include GILEAD SCIENCES, AMGEN-T and VERTEX PHARMACEUTICALS.

What is the base currency of IBBQ?

The base currency of IBBQ is USD.

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight